Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind,

Shengli Xia1, Yuntao Zhang2, Yanxia Wang1

  • 1Henan Provincial Center for Disease Control and Prevention, Henan, China.

Abstract

Insights

The inactivated SARS-CoV-2 vaccine BBIBP-CorV demonstrated safety and induced immune responses in adults. Two doses of 4 μg were more effective than a single 8 μg dose in generating neutralizing antibodies against COVID-19.

Area of Science:

  • Virology and Immunology
  • Vaccine Development
  • Infectious Disease Research

Background:

  • The COVID-19 pandemic necessitates rapid development and testing of vaccine candidates.
  • BBIBP-CorV is an inactivated vaccine candidate against SARS-CoV-2, the virus causing COVID-19.
  • Assessing the safety and immunogenicity of BBIBP-CorV in humans is crucial.

Purpose of the Study:

  • To evaluate the safety and immunogenicity of the BBIBP-CorV vaccine in human participants.
  • To determine optimal dosage and schedule for the inactivated SARS-CoV-2 vaccine.
  • To assess neutralizing antibody responses against SARS-CoV-2 following vaccination.

Main Methods:

  • A randomized, double-blind, placebo-controlled phase 1/2 trial was conducted in China.
  • Participants received two doses of vaccine (2, 4, or 8 μg) or placebo in Phase 1 (ages 18-80).
  • Phase 2 involved adults (18-59) receiving single or two doses of 4 or 8 μg vaccine or placebo.

Main Results:

  • BBIBP-CorV was safe and well-tolerated across all tested doses and age groups.
  • Mild to moderate adverse reactions, primarily fever, were reported in vaccine recipients.
  • Two-dose regimens of 4 μg BBIBP-CorV induced significantly higher neutralizing antibody titers compared to a single 8 μg dose.

Conclusions:

  • The inactivated SARS-CoV-2 vaccine BBIBP-CorV is safe and elicits humoral immune responses.
  • Two-dose vaccination schedules, particularly 4 μg on days 0 and 21 or 0 and 28, are superior for antibody generation.
  • BBIBP-CorV shows promise as a COVID-19 vaccine candidate.

Related Concept Videos

Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
107
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
69
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
101
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
287